From: GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
Median (IQR) | Group I (Cases N = 60 | Group II (Control) N = 28 | p value |
---|---|---|---|
Hb (g/dL) | 9.8 (9.0—10.5) | 12.1 (11.9 – 12.3) | < 0.0001* |
MCV (fL) | 85.0 (79.3 – 88.0) | 88.0 (85.0 – 92.0) | 0.003* |
MCH | 27.0 (26.0 – 29.0) | 28.5 (28.0 – 30.8) | < 0.001* |
MCHC | 32.0 (30.3 – 33.0) | 33.0 (33.0 – 35.0) | < 0.0001* |
Urea (mg/dl) | 96.5 (39.8 – 124.3) | 25.5 (25.0 – 28.0) | < 0.0001* |
Creat (mg/dl) | 2.2 (0.9 – 4.3) | 0.6 (0.5 – 0.7) | < 0.0001* |
eGFR (ml/min) | 28.6 (22.3 – 67.2) | 130.0 (120.8 – 152.3) | < 0.0001* |
A/C ratio | 322.0 (153.0 – 1073.0) | ––– | –––- |
ALT (U/L) | 22.0 (15.0 – 30.0) | 22.0 (18.5 – 27.0) | 0.689 |
AST (U/L) | 25.0 (21.0 – 33.0) | 23.5 (18.8 – 27.8) | 0.119 |
Iron (µg/dL) | 52.0 (36.0 – 88.3) | 100.0 (85.8 – 106.8) | < 0.0001* |
Ferritin (μg/l) | 755.0 (181.5 – 1330.5) | 95.0 (88.0 – 102.0) | < 0.0001* |
TIBC (µg/dL) | 254.0 (187.8 – 287.5) | 161.5 (153.5 – 189.5) | < 0.0001* |
Transferrin | 25.0 (16.3 – 42.0) | 25.0 (19.0 – 34.3) | 0.74 |
CRP (mg/l) | 12.0 (3 – 24.0) | 3 (2—5) | < 0.0001* |
Hepcidin (ng/mL) | 338.5 (276.0 – 505.5) | 303.0 (215.0 – 387.0) | 0.047* |
GDF (ng/L) | 1277.2 (1072.3 – 1376.6) | 401.6 (298.6 – 594.5) | < 0.0001* |